Total Payments
$8,158
2024 Payments
$550.19
Companies
39
Transactions
295
Medicare Patients
7,537
Medicare Billing
$738,482
Payment Breakdown by Category
Food & Beverage$5,916 (72.5%)
Travel$2,021 (24.8%)
Education$221.48 (2.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,916 | 285 | 72.5% |
| Travel and Lodging | $2,021 | 4 | 24.8% |
| Education | $221.48 | 6 | 2.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic Vascular, Inc. | $1,776 | 8 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $831.78 | 45 | $0 (2024) |
| BIOTRONIK INC. | $819.79 | 3 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $776.09 | 43 | $0 (2024) |
| Boston Scientific Corporation | $455.13 | 19 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $414.79 | 16 | $0 (2023) |
| Merck Sharp & Dohme LLC | $371.82 | 16 | $0 (2023) |
| Amgen Inc. | $310.45 | 18 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $291.63 | 17 | $0 (2024) |
| PFIZER INC. | $279.53 | 19 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $550.19 | 22 | Boston Scientific Corporation ($195.46) |
| 2023 | $834.19 | 40 | Merck Sharp & Dohme LLC ($218.83) |
| 2022 | $817.78 | 45 | Novartis Pharmaceuticals Corporation ($194.90) |
| 2021 | $602.99 | 30 | Janssen Pharmaceuticals, Inc ($186.20) |
| 2020 | $563.42 | 30 | AstraZeneca Pharmaceuticals LP ($192.60) |
| 2019 | $1,112 | 51 | Novartis Pharmaceuticals Corporation ($176.01) |
| 2018 | $3,199 | 48 | Medtronic Vascular, Inc. ($1,776) |
| 2017 | $478.51 | 29 | Novartis Pharmaceuticals Corporation ($88.87) |
All Payment Transactions
295 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/09/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $20.70 | General |
| Category: Cardiovascular | ||||||
| 09/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: Diabetes | ||||||
| 09/05/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $26.02 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 08/26/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/21/2024 | Philips North America LLC | (CK4) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $20.75 | General |
| Category: Medical Device | ||||||
| 06/26/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/20/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/17/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Diabetes | ||||||
| 06/12/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: Not Applicable | ||||||
| 06/07/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: Not Applicable | ||||||
| 05/23/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $27.21 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 05/21/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $30.46 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/13/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $26.92 | General |
| Category: NEUROLOGY | ||||||
| 05/01/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/23/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $25.11 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 04/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: Diabetes | ||||||
| 03/13/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: Cardiology | ||||||
| 03/12/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: Genetic Disease | ||||||
| 03/06/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $117.12 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 02/28/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/21/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $23.98 | General |
| Category: Genetic Disease | ||||||
| 12/11/2023 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $30.64 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/04/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $13.03 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/08/2023 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,213 | 1,725 | $526,950 | $137,826 |
| 2022 | 19 | 1,590 | 2,319 | $859,370 | $186,611 |
| 2021 | 18 | 2,481 | 3,593 | $1.2M | $229,387 |
| 2020 | 22 | 2,253 | 3,499 | $980,945 | $184,657 |
Total Patients
7,537
Total Services
11,136
Medicare Billing
$738,482
Procedure Codes
81
All Medicare Procedures & Services
81 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 236 | 242 | $165,770 | $36,527 | 22.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 190 | 352 | $96,800 | $32,301 | 33.4% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 75 | 75 | $86,250 | $27,785 | 32.2% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 52 | 208 | $29,120 | $9,305 | 32.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 89 | 128 | $24,320 | $8,691 | 35.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 46 | 46 | $16,100 | $5,903 | 36.7% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 88 | 89 | $40,050 | $4,527 | 11.3% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 73 | 77 | $29,000 | $3,894 | 13.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 220 | 338 | $23,660 | $3,699 | 15.6% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 35 | 59 | $10,325 | $3,654 | 35.4% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2023 | 27 | 28 | $1,960 | $566.19 | 28.9% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 20 | 20 | $1,300 | $380.80 | 29.3% |
| 93246 | Heart rhythm recording of continous external ekg over 8-15 days | Office | 2023 | 27 | 28 | $1,120 | $276.75 | 24.7% |
| 93242 | Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 20 | 20 | $800.00 | $205.00 | 25.6% |
| J0280 | Injection, aminophyllin, up to 250 mg | Office | 2023 | 15 | 15 | $375.00 | $112.28 | 29.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 213 | 221 | $190,935 | $36,309 | 19.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 178 | 356 | $102,550 | $32,863 | 32.0% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 67 | 67 | $92,055 | $25,972 | 28.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 127 | 299 | $74,210 | $25,242 | 34.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 237 | 243 | $164,805 | $13,771 | 8.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 113 | 115 | $37,625 | $12,671 | 33.7% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2022 | 48 | 192 | $21,880 | $8,799 | 40.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 65 | 106 | $20,690 | $6,607 | 31.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 37 | 37 | $15,450 | $4,178 | 27.0% |
| 93280 | Programming of dual lead pacemaker system | Office | 2022 | 45 | 67 | $13,510 | $3,912 | 29.0% |
About Dr. Srinivas Atri, MD
Dr. Srinivas Atri, MD is a Cardiovascular Disease healthcare provider based in Langhorne, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1669434460.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Srinivas Atri, MD has received a total of $8,158 in payments from pharmaceutical and medical device companies, with $550.19 received in 2024. These payments were reported across 295 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($5,916).
As a Medicare-enrolled provider, Atri has provided services to 7,537 Medicare beneficiaries, totaling 11,136 services with total Medicare billing of $738,482. Data is available for 4 years (2020–2023), covering 81 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Langhorne, PA
- Active Since 04/05/2006
- Last Updated 04/27/2016
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1669434460
Products in Payments
- XARELTO (Drug) $831.78
- ENTRESTO (Drug) $564.68
- ELIQUIS (Drug) $378.63
- VERQUVO (Drug) $371.82
- BRILINTA (Drug) $214.59
- LEQVIO (Drug) $211.41
- Repatha (Biological) $196.22
- WATCHMAN FLX (Device) $195.46
- LifeVest (Device) $171.34
- WATCHMAN (Device) $158.49
- TEGSEDI (Drug) $156.13
- Mitra Clip system (Device) $115.74
- Corlanor (Drug) $114.23
- Vascepa (Drug) $99.98
- Rybelsus (Drug) $94.81
- Arcalyst (Drug) $93.96
- INJECTAFER (Drug) $90.28
- FARXIGA (Drug) $82.19
- CAMZYOS (Drug) $79.04
- VYNDAQEL (Drug) $78.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Langhorne
Rakesh Shah, M.d, M.D
Cardiovascular Disease — Payments: $136,380
Cardiovascular Disease $136,380
Frank Ammaturo, M.d, M.D
Cardiovascular Disease — Payments: $25,869
Cardiovascular Disease $25,869
Anand Haridas, M.d, M.D
Cardiovascular Disease — Payments: $18,256
Cardiovascular Disease $18,256
Andrew Friedman, Do, DO
Cardiovascular Disease — Payments: $9,374
Cardiovascular Disease $9,374
Eyad Kanawati, M.d, M.D
Cardiovascular Disease — Payments: $8,981
Cardiovascular Disease $8,981
Dr. Ranga Rao, Md, MD
Cardiovascular Disease — Payments: $8,305
Cardiovascular Disease $8,305